Assessing risk for preclinical β-amyloid pathology with APOE, cognitive, and demographic information

INTRODUCTION: Clinical trials in Alzheimer's disease are aimed at early stages of disease, including preclinical Alzheimer's disease. The high cost and time required to screen large numbers of participants for Aβ pathology impede the development of novel drugs. This study's objective...

Ausführliche Beschreibung

Gespeichert in:
Bibliographische Detailangaben
Veröffentlicht in:Alzheimers Dement (Amst)
Hauptverfasser: Insel, Philip S., Palmqvist, Sebastian, Mackin, R. Scott, Nosheny, Rachel L., Hansson, Oskar, Weiner, Michael W., Mattsson, Niklas
Format: Artigo
Sprache:Inglês
Veröffentlicht: Elsevier 2016
Schlagworte:
Cognitive & Behavioral Assessment
Online Zugang:https://ncbi.nlm.nih.gov/pmc/articles/PMC5045949/
https://ncbi.nlm.nih.gov/pubmed/27722193
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1016/j.dadm.2016.07.002
Tags: Tag hinzufügen
Keine Tags, Fügen Sie den ersten Tag hinzu!

Ähnliche Einträge